DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20172688

Evaluation of prevalence, clinical spectrum and outcome of acute ITP in children in a tertiary care centre in Odisha, India

Jyotiranjan Champatiray, Deepak Kumar Behera, Akhil Krishnamoorthy, Shreesh Bhat

Abstract


Background: Idiopathic thrombocytopenic purpura (ITP), also known as immune thrombocytopenic purpura is one of the commonest bleeding disorders encountered in children between the ages of 2 to 10 years affecting both sexes. The objectives of the study were to collect the prospectively data including age, gender, bleeding type, platelet count and other laboratory tests, treatments, responses to treatment and outcomes in children with acute ITP from 1month to 14 years of age over a period of two years.

Methods: The present study was conducted in the Department of Paediatrics Shrirama Chandra Bhanj, Medical College and Hospital and Sardar Vallabhbhai Patel Post Graduate Institute of Paediatrics, Cuttack during the period October 2011-Septmber 2013.

Results: Total 36 cases of hospitalized acute ITP patients were studied out of 29200 cases. Prevalence of acute ITP was found to be 12.3 per 10,000 of all hospitalized children above 1 month. Male children outnumbered female children by Ratio 1.2. Past history of URTI was present in 78% of cases. Petechaie/purpura was the universal presenting features followed by Oral / Gum bleeding in 67% of cases. 8% of patient experienced clinical bleeding requiring blood transfusion and platelet transfusion. Mean duration of Hospital stay was 6.34 days. Maximum number of Patients (69%) had complete recovery and 14% each had persistent and chronic course.

Conclusions: ITP is a common pediatrics disease presenting at any age with low morbidity and mortality. Most children with acute ITP recover in weeks to months. A long-term hospital based prospective study is suggested to know any significant risk factor in patient presenting with acute ITP.


Keywords


Immune Thrombocytopenic Purpura (ITP), Tertiary Care

Full Text:

PDF

References


Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an International Working Group. Blood. 2009;113:2386-93.

Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85:174-80.

De Mattia D, Del Vecchio GC, Russo G, De Santis A, Ramenghi U, Notarangelo L et al. AIEOP-ITP Study Group. Management of chronic childhood immune thrombocytopenic purpura: AIEOP Consensus Guidelines. Acta Haematol. 2010;123:96-109.

Lilleyman JS. On behalf of the Pediatric Haematology Forum of the British Society of Haematology. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child. 1994;71:251-3.

Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951;38:1-10.

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-86.

Blanchette V. Childhood chronic immune thrombo-cytopenic purpura (ITP). Blood Rev. 2002;16:23-6.

Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174-80.

Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K. Immune thrombocytopenic purpurain childhood in Norway: A prospective, population-based registration. Pediatr Hematol Oncol. 2000;17:551-8.

Lilleyman JS. Intracranial hemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child. 1994;71:251-3.

Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006;4:2377-83.

Watts RG. Idiopathic thrombocytopenic purpura: a10-year natural history study at the children’s hospital of Alabama. Clin Pediatr (Phila). 2004;43:691-702.

Lusher JM, Iyer R. Idiopathic thrombocytopenic purpura in children. Semin Thromb Hemost. 1977;3:175-99.

Kuhne T, Imbach P, Bolton-Maggs PH, Berchtol W, Blanchette V, Buchanan GR et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood. Lancet. 2001;358(9299):2122-5.

Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N EnglJ Med. 1966;275:352-6.

Blanchette VS, Carcao M. Childhood acute immune thrombocytopenic purpura:20 years later. Semin Thromb Hemost. 2003;29:605.

Lilleyman JS. On behalf of the Pediatric Haematology Forum of the British Society of Haematology. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child. 1994;71:251-3.

Lammi AT, Lovric VA. Idiopathic thrombocytopenic purpura: an epidemiologic study. Pediatrics. 1973; 83:31-5.

Souid A, Sadowitz PD. Acute childhood immune thrombocytopenic purpura diagnosis and treatment. Clin Pediatr. 1995; 34:487-94.

George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3-40.

Watts RG. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the children’s hospital of Alabama. Clin Pediatr. 2004;43:691-702.

Gadner H. Management of immune thrombocytopenic purpura in children. Rev Clin Exp Hematol. 2001; 5:201-21.